English | Español

Eli Lilly And Company
Ruth de Jauregui | Dec 4, 2016

Potential Alzheimer's drug fails to produce significant results
Ruth de Jauregui | Dec 4, 2016

Bridging the gap between patients, researchers
Robert Hadley | Dec 4, 2016

Patient advocacy, collaboration discussed at Brussels EFPIA meeting
Amanda Rupp | Oct 16, 2016

Health experts recommend adjusting expectations related to Alzheimer’s treatment goal
Amanda Rupp | Sep 18, 2016

Alzheimer’s Readiness Award granted to Boston mayor, local chapter of Alzheimer’s Association
Amanda Rupp | Aug 19, 2016

Lilly announces new promotions, retiree
Amanda Rupp | Jul 30, 2016

Potential connection found between Alzheimer’s progression, tau pathology
Amanda Rupp | Jul 7, 2016

Jardiance limits kidney disease risk for type 2 diabetes patients with cardiovascular disease

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments